A previous study demonstrated that artemether (Art), an artemisinin derivative applied in the treatment option for malaria, could protect against kidney injury in T2D db/db mice partially via increasing MPC1 and MPC2 levels14. The gene discussed is MPC1; the disease is type 2 diabetes mellitus.